Clinical Trial Update: A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating ixazomib in combination with lenalidomide and dexamethasone for multiple myeloma. The study is active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• NINLARO (ixazomib)
• Revlimid (lenalidomide)

Snippet

Sponsor: Takeda | Conditions: Multiple Myeloma | Phase 4 | Status: ACTIVE_NOT_RECRUITING